Compare

NeuroSense Therapeutics Ltd. vs Ocean Biomedical, Inc. vs Aspire Biopharma Holdings, Inc. vs Semnur Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	NeuroSense Therapeutics Ltd. NRSN	Ocean Biomedical, Inc. OCEALast annual report: year ended 2024-12-31	Aspire Biopharma Holdings, Inc. ASBP	Semnur Pharmaceuticals, Inc. SMNR
Year ended	2025-12-31	2024-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	$6.2K	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	-1.9%	n/a
Operating margin	n/a	n/a	n/m	n/a
Net margin	n/a	n/a	n/m	n/a
Net income	-$11.12M	-$9.48M	-$24.48M	-$160.42M
EPS (Diluted)	-$0.44	-$0.34	-$16.38	-$0.78
Operating cash flow	-$7.67M	-$4.18M	-$4.92M	-$5.87M
Free cash flow	-$7.68M	n/a	n/a	n/a
Cash & equivalents	$166.0K	n/a	n/a	$20.0K
Total assets	$1.03M	$902.0K	$1.31M	$1.35M
Total liabilities	$2.59M	$98.52M	$7.69M	$22.10M
Shareholders' equity	-$1.56M	-$97.62M	-$6.38M	-$20.75M
Return on year-end equity	n/a	n/a	n/a	n/a
Shares outstanding	32.56M	34.87M	3.53M	230.21M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	NeuroSense Therapeutics Ltd.	Ocean Biomedical, Inc.	Aspire Biopharma Holdings, Inc.	Semnur Pharmaceuticals, Inc.
Latest	n/a	n/a	$6.2K Ended 2025-12-31	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a